Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.970
-0.210 (-4.05%)
Sep 25, 2025, 3:33 PM EDT - Market open
Aurora Cannabis Revenue
Aurora Cannabis had revenue of 98.02M CAD in the quarter ending June 30, 2025, with 17.48% growth. This brings the company's revenue in the last twelve months to 357.88M, up 28.58% year-over-year. In the fiscal year ending March 31, 2025, Aurora Cannabis had annual revenue of 343.29M with 27.32% growth.
Revenue (ttm)
357.88M CAD
Revenue Growth
+28.58%
P/S Ratio
1.12
Revenue / Employee
333,533 CAD
Employees
1,073
Market Cap
292.73M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 343.29M | 73.66M | 27.32% |
Mar 31, 2024 | 269.64M | 45.83M | 20.48% |
Mar 31, 2023 | 223.80M | 2.47M | 1.11% |
Jun 30, 2022 | 221.34M | -23.91M | -9.75% |
Jun 30, 2021 | 245.25M | -23.45M | -8.73% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ACB News
- 7 days ago - Best Cannabis Stocks in Canada to Watch Now: Technical Signals and Market Outlook - MarijuanaStocks
- 7 days ago - Aurora Announces Investment into German Manufacturing Facility - PRNewsWire
- 13 days ago - 3 Marijuana Stocks For Better Gains This Month - MarijuanaStocks
- 16 days ago - Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case Studies - PRNewsWire
- 17 days ago - Aurora, a Leading Global Medical Cannabis Company, Attends the H.C. Wainwright 27th Annual Global Investment Conference - PRNewsWire
- 4 weeks ago - 3 Top Canadian Marijuana Stocks Impacted By The Cannabis Industry - MarijuanaStocks
- 6 weeks ago - Top Canadian Marijuana Stocks If Federal Reform Passes In The USA - MarijuanaStocks
- 6 weeks ago - Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia - PRNewsWire